Savient Pharmaceuticals, Inc. (SVNT) Misses Q2 Loss Views by 13c
Tweet Send to a FriendGet Alerts SVNT Hot Sheet
Price: $0.74 --0%
EPS Growth %: +30.6%
Financial Fact:
Other (expense) income, net: 506K
Today's EPS Names:
CLC, FNSR, MU, More
EPS Growth %: +30.6%
Financial Fact:
Other (expense) income, net: 506K
Today's EPS Names:
CLC, FNSR, MU, More
Trade SVNT Now!
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) reported Q2 EPS of ($0.43), $0.13 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $2 million versus the consensus estimate of $2.77 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- La-Z-boy, Inc. (LZB) Tops Q4 EPS by 5c
- Five Below (FIVE) Tops Q1 EPS by 1c, Boosts FY13 Outlook
- Savient (SVNT) Increases Price on KRYSTEXXA to $5,390
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
